Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Publisher Name :
Date: 12-Feb-2019
No. of pages: 137

A biomarker is, according to the US National Institutes of Health, "a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention."

Biomarkers make take the form of cellular characteristics, metabolites (e.g. sugars, lipids and hormones), molecular variations, or physical features (e.g., clinical symptoms) and are assessed accordingly, via measurement, annotation, documents, and images.

Increasingly, the discovery of novel biomarkers is closely associated with the advances in molecular biology techniques that can be accessed through analysis of DNA, RNA or proteins.

We can discriminate four main types of molecular biomarkers:

• Genomic biomarkers: Based on the analysis of DNA (deoxyribonucleic acid) profiles, especially the analysis of SNPs (single nucleotide polymorphisms), i.e. identification of punctual variations in genomic DNA.

• Transcriptomic biomarkers: Base on the analysis of RNA expression profiles.

• Proteomic biomarkers: Base on the analysis of the protein profiles.

• Metabolomic biomarkers: Base on the analysis of metabolites (metabolites are the intermediates and products of metabolism).

Commercializing biomarkers is the path that a biomarker could be used in therapeutic or diagnostic. In this report mainly covers consumables, services, software of this market.

Scope of the Report:

In the last several years, global market of Commercializing Biomarkers in Therapeutic and Diagnostic Applications developed rapidly, with an average growth rate of 8.49%. In 2015, the consumables revenue growth rate was about 8.5%, the services revenue growth rate was nearly 8.6%, and the consumables revenue growth rate was the highest among the Commercializing Biomarkers in Therapeutic and Diagnostic Applications Industry.

North America is the largest consumer of Commercializing Biomarkers, with the sales market share nearly 42%.

The second place is Europe, following North America with the sales market share of 31%. Japan and China is also the important market, with the total sales marker share of 18.6%.

The worldwide market for Commercializing Biomarkers in Therapeutic and Diagnostic Applications is expected to grow at a CAGR of roughly 6.1% over the next five years, will reach 24400 million US$ in 2024, from 17200 million US$ in 2019, according to a new GIR (Global Info Research) study.

This report focuses on the Commercializing Biomarkers in Therapeutic and Diagnostic Applications in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

- Roche

- Dako (Agilent Technologies)

- Merck

- BD

- Abbott

- Genesys Biolabs (20/20GeneSystems)

- Affymetrix

- Agendia

- ALMAC

- Arrayit

- Biocartic

- BG Medicine

- KEGG EXPRESSION Database

- Thermo Fisher

- BGI

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Consumables

- Services

- Software

Market Segment by Applications, can be divided into

- Oncology

- Cardiology

- Neurology

- Other

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Commercializing Biomarkers in Therapeutic and Diagnostic Applications product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Commercializing Biomarkers in Therapeutic and Diagnostic Applications, with price, sales, revenue and global market share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications in 2017 and 2018.

Chapter 3, the Commercializing Biomarkers in Therapeutic and Diagnostic Applications competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Commercializing Biomarkers in Therapeutic and Diagnostic Applications breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Commercializing Biomarkers in Therapeutic and Diagnostic Applications market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Commercializing Biomarkers in Therapeutic and Diagnostic Applications sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Market Overview
1.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction
1.2 Market Analysis by Type
1.2.1 Consumables
1.2.2 Services
1.2.3 Software
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Cardiology
1.3.3 Neurology
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Dako (Agilent Technologies)
2.2.1 Business Overview
2.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Merck
2.3.1 Business Overview
2.3.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 BD
2.4.1 Business Overview
2.4.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Abbott
2.5.1 Business Overview
2.5.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Genesys Biolabs (20/20GeneSystems)
2.6.1 Business Overview
2.6.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Affymetrix
2.7.1 Business Overview
2.7.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Agendia
2.8.1 Business Overview
2.8.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 ALMAC
2.9.1 Business Overview
2.9.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Arrayit
2.10.1 Business Overview
2.10.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Biocartic
2.11.1 Business Overview
2.11.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Biocartic Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 BG Medicine
2.12.1 Business Overview
2.12.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 BG Medicine Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 KEGG EXPRESSION Database
2.13.1 Business Overview
2.13.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 KEGG EXPRESSION Database Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Thermo Fisher
2.14.1 Business Overview
2.14.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Thermo Fisher Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 BGI
2.15.1 Business Overview
2.15.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 BGI Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturer Market Share in 2018
3.3.2 Top 6 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Analysis by Regions
4.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Regions
4.1.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Regions (2014-2019)
4.1.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Regions (2014-2019)
4.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
4.3 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
4.5 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
5 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Country
5.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Country
5.1.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Country (2014-2019)
5.1.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Country (2014-2019)
5.2 United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
5.3 Canada Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
5.4 Mexico Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
6 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Country
6.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Country
6.1.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Country (2014-2019)
6.1.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Country (2014-2019)
6.2 Germany Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
6.3 UK Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
6.4 France Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
6.5 Russia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
6.6 Italy Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
7 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Country
7.1 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Country (2014-2019)
7.2 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
7.3 Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
7.4 Korea Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
7.5 India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
8 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Country
8.1 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Country
8.1.1 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Country (2014-2019)
8.1.2 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Country (2014-2019)
8.2 Brazil Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
8.3 Argentina Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
8.4 Colombia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
9 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Countries
9.1 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
9.3 Turkey Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
9.4 Egypt Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
9.5 Nigeria Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
9.6 South Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
10 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Segment by Type
10.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Type (2014-2019)
10.1.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Type (2014-2019)
10.2 Consumables Sales Growth and Price
10.2.1 Global Consumables Sales Growth (2014-2019)
10.2.2 Global Consumables Price (2014-2019)
10.3 Services Sales Growth and Price
10.3.1 Global Services Sales Growth (2014-2019)
10.3.2 Global Services Price (2014-2019)
10.4 Software Sales Growth and Price
10.4.1 Global Software Sales Growth (2014-2019)
10.4.2 Global Software Price (2014-2019)
11 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Segment by Application
11.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Application (2014-2019)
11.2 Oncology Sales Growth (2014-2019)
11.3 Cardiology Sales Growth (2014-2019)
11.4 Neurology Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2019-2024)
12.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Growth Rate (2019-2024)
12.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast by Regions (2019-2024)
12.2.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2019-2024)
12.2.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2019-2024)
12.2.3 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2019-2024)
12.2.4 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2019-2024)
12.2.5 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2019-2024)
12.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast by Type (2019-2024)
12.3.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Forecast by Type (2019-2024)
12.3.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share Forecast by Type (2019-2024)
12.4 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast by Application (2019-2024)
12.4.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Forecast by Application (2019-2024)
12.4.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Picture
Table Product Specifications of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Figure Global Sales Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2018
Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Types for Major Manufacturers
Figure Consumables Picture
Figure Services Picture
Figure Software Picture
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Applications in 2018
Figure Oncology Picture
Figure Cardiology Picture
Figure Neurology Picture
Figure Other Picture
Figure United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure France Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure UK Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Dako (Agilent Technologies) Basic Information, Manufacturing Base and Competitors
Table Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table BD Basic Information, Manufacturing Base and Competitors
Table BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Genesys Biolabs (20/20GeneSystems) Basic Information, Manufacturing Base and Competitors
Table Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Affymetrix Basic Information, Manufacturing Base and Competitors
Table Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Agendia Basic Information, Manufacturing Base and Competitors
Table Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table ALMAC Basic Information, Manufacturing Base and Competitors
Table ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Arrayit Basic Information, Manufacturing Base and Competitors
Table Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Biocartic Basic Information, Manufacturing Base and Competitors
Table Biocartic Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table Biocartic Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table BG Medicine Basic Information, Manufacturing Base and Competitors
Table BG Medicine Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table BG Medicine Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table KEGG EXPRESSION Database Basic Information, Manufacturing Base and Competitors
Table KEGG EXPRESSION Database Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table KEGG EXPRESSION Database Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table Thermo Fisher Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table BGI Basic Information, Manufacturing Base and Competitors
Table BGI Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table BGI Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturer (2017-2018)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2017
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2018
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturer (2017-2018)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2017
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2018
Figure Top 3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturer (Revenue) Market Share in 2018
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2014-2019)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Regions (2014-2019)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Regions (2014-2019)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Regions (2014-2019)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Regions in 2014
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Regions in 2018
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2014-2019)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2014-2019)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2014-2019)
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries in 2014
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries in 2018
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2014-2019)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries (2014-2019)
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2014
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2018
Figure United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Canada Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Mexico Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2014-2019)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2014-2019)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2014-2019)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2014-2019)
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2017
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2018
Figure Germany Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure UK Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure France Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Russia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Italy Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2014-2019)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries 2018
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2014-2019)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries 2018
Figure China Commercializing Biomarkers in Therapeutic and Diag
  • Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Growth (Status and Outlook) 2019-2024
    Published: 13-Nov-2019        Price: US 3660 Onwards        Pages: 133
    According to this study, over the next five years the Commercializing Biomarkers in Therapeutic and Diagnostic Applications market will register a 5.0% CAGR in terms of revenue, the global market size will reach US$ 21360 million by 2024, from US$ 17600 million in 2019. In particular, this report presents the global revenue market share of key companies in Commercializing Biomarkers in Therapeutic and Diagnostic Applications business, shared in Chapter 3. This report presents a co......
  • Global Circulating Biomarker Market Professional Survey Report 2019
    Published: 06-Nov-2019        Price: US 3500 Onwards        Pages: 109
    The global Circulating Biomarker market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Circulating Biomarker volume and value at global level, regional level and company level. From a global perspective, this report represents overall Circulating Biomarker market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent co......
  • 2017-2025 World Cell Surface Markers Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 31-Oct-2019        Price: US 2800 Onwards        Pages: 109
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Cell Surface Markers , covering Global t......
  • 2017-2025 World Central Nervous System (CNS) Biomarkers Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 31-Oct-2019        Price: US 2800 Onwards        Pages: 112
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Central Nervous System (CNS) Biomarkers ......
  • Global Liquid Biopsy Market: Analysis By Biomarkers (C-Tumor Cells, C-Tumor DNA, Vesicles), Cancer Type, By Product (Instruments, Reagents), By Region, By Country (2019 Edition): Opportunities and Forecast (2017-2024)
    Published: 31-Oct-2019        Price: US 1800 Onwards        Pages: 200
    Executive Summary The Liquid Biopsy was valued at USD 899.55 million for the year 2018. Over the recent years, Liquid Biopsy has been witnessing considerable growth on the back of growing focus on immunotherapy to cure cancer and shifting trend towards precision medicine along with high per capita healthcare expenditure and rapid adoption of novel diagnostic test by oncologist. Further, rising awareness for the early detection of cancer and sharp rise in its i......
  • 2017-2025 World Biomarkers Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 28-Oct-2019        Price: US 2800 Onwards        Pages: 100
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Biomarkers , covering Global total and m......
  • Global Cell Surface Markers Market Professional Survey Report 2019
    Published: 23-Oct-2019        Price: US 3500 Onwards        Pages: 104
    The global Cell Surface Markers market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cell Surface Markers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cell Surface Markers market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consu......
  • Global Molecular Biomarkers for Cancer Detection and Management Market Study 2016-2026, by Segment (Screening, Detection, Risk Assessment, and Monitoring Biomarkers, Prognosis and Prediction Biomarkers,) , by Market (Hospital, Research Institutions,) , by Company (Alere, Atossa Genetics,)
    Published: 21-Oct-2019        Price: US 1800 Onwards        Pages: 65
    Summary The global Molecular Biomarkers for Cancer Detection and Management market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - Screening, Detection, Risk Assessment, and Monitoring Biomarkers - Prognosis and Prediction Biomarkers - Companion Diagnostic Biomarkers Demand Coverage (Market Size & Forecast, Consumer ......
  • Predisposition Biomarkers: Technologies and Global Markets
    Published: 17-Oct-2019        Price: US 3950 Onwards        Pages: 72
    Report Includes: - An overview of technologies and global markets for the predisposition biomarkers - Analyses of the global market trends with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024 - Information on recent key technical advances in different predisposition biomarkers, as well as the extent of adoption by commercial customers and regulatory authorities - Identification of key areas of growth and the ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs